Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#patient selection ×

Regulatorische Updates

23. Aug. 2026•1 Min. Lesezeit

PMDA Approves SHINSA CDx for Identifying Eligible Patients

Japan’s PMDA has approved the SHINSA companion diagnostic (CDx) to help identify patients eligible for specific therapies, updated June 16, 2026.